nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—ORM1—Vandetanib—thyroid cancer	0.338	0.414	CbGbCtD
Prazosin—ABCG2—Vandetanib—thyroid cancer	0.206	0.253	CbGbCtD
Prazosin—ABCG2—Sorafenib—thyroid cancer	0.124	0.152	CbGbCtD
Prazosin—ABCG2—Doxorubicin—thyroid cancer	0.0755	0.0924	CbGbCtD
Prazosin—ABCB1—Sorafenib—thyroid cancer	0.0448	0.0549	CbGbCtD
Prazosin—ABCB1—Doxorubicin—thyroid cancer	0.0272	0.0333	CbGbCtD
Prazosin—Cataract—Vandetanib—thyroid cancer	0.00456	0.04	CcSEcCtD
Prazosin—Pancreatitis—Vandetanib—thyroid cancer	0.00267	0.0234	CcSEcCtD
Prazosin—Gynaecomastia—Sorafenib—thyroid cancer	0.00262	0.023	CcSEcCtD
Prazosin—Pollakiuria—Vandetanib—thyroid cancer	0.00252	0.022	CcSEcCtD
Prazosin—Epistaxis—Vandetanib—thyroid cancer	0.00229	0.0201	CcSEcCtD
Prazosin—MT3—head—thyroid cancer	0.00223	0.102	CbGeAlD
Prazosin—KCNH7—head—thyroid cancer	0.00223	0.102	CbGeAlD
Prazosin—Bradycardia—Vandetanib—thyroid cancer	0.00222	0.0194	CcSEcCtD
Prazosin—Alopecia—Vandetanib—thyroid cancer	0.00193	0.0169	CcSEcCtD
Prazosin—Pancreatitis—Sorafenib—thyroid cancer	0.0018	0.0158	CcSEcCtD
Prazosin—Vision blurred—Vandetanib—thyroid cancer	0.00179	0.0157	CcSEcCtD
Prazosin—Abdominal discomfort—Sorafenib—thyroid cancer	0.00176	0.0154	CcSEcCtD
Prazosin—Erectile dysfunction—Sorafenib—thyroid cancer	0.00169	0.0148	CcSEcCtD
Prazosin—Loss of consciousness—Vandetanib—thyroid cancer	0.00167	0.0146	CcSEcCtD
Prazosin—Arthralgia—Vandetanib—thyroid cancer	0.00162	0.0142	CcSEcCtD
Prazosin—KCNH6—head—thyroid cancer	0.00159	0.0723	CbGeAlD
Prazosin—Dry mouth—Vandetanib—thyroid cancer	0.00158	0.0138	CcSEcCtD
Prazosin—MT3—lymph node—thyroid cancer	0.00156	0.0711	CbGeAlD
Prazosin—Oedema—Vandetanib—thyroid cancer	0.00155	0.0136	CcSEcCtD
Prazosin—Epistaxis—Sorafenib—thyroid cancer	0.00155	0.0135	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00141	0.0124	CcSEcCtD
Prazosin—Insomnia—Vandetanib—thyroid cancer	0.0014	0.0123	CcSEcCtD
Prazosin—Paraesthesia—Vandetanib—thyroid cancer	0.00139	0.0122	CcSEcCtD
Prazosin—Dyspnoea—Vandetanib—thyroid cancer	0.00138	0.0121	CcSEcCtD
Prazosin—Tinnitus—Sorafenib—thyroid cancer	0.00137	0.012	CcSEcCtD
Prazosin—Flushing—Sorafenib—thyroid cancer	0.00137	0.012	CcSEcCtD
Prazosin—Fatigue—Vandetanib—thyroid cancer	0.00134	0.0117	CcSEcCtD
Prazosin—Pain—Vandetanib—thyroid cancer	0.00133	0.0116	CcSEcCtD
Prazosin—Constipation—Vandetanib—thyroid cancer	0.00133	0.0116	CcSEcCtD
Prazosin—Alopecia—Sorafenib—thyroid cancer	0.0013	0.0114	CcSEcCtD
Prazosin—Body temperature increased—Vandetanib—thyroid cancer	0.00123	0.0107	CcSEcCtD
Prazosin—SLC22A3—saliva-secreting gland—thyroid cancer	0.00117	0.0534	CbGeAlD
Prazosin—Syncope—Sorafenib—thyroid cancer	0.00115	0.0101	CcSEcCtD
Prazosin—Loss of consciousness—Sorafenib—thyroid cancer	0.00113	0.00986	CcSEcCtD
Prazosin—Asthenia—Vandetanib—thyroid cancer	0.00111	0.00974	CcSEcCtD
Prazosin—Pruritus—Vandetanib—thyroid cancer	0.0011	0.0096	CcSEcCtD
Prazosin—Arthralgia—Sorafenib—thyroid cancer	0.00109	0.00955	CcSEcCtD
Prazosin—Dry mouth—Sorafenib—thyroid cancer	0.00107	0.00934	CcSEcCtD
Prazosin—Diarrhoea—Vandetanib—thyroid cancer	0.00106	0.00929	CcSEcCtD
Prazosin—Shock—Sorafenib—thyroid cancer	0.00103	0.00901	CcSEcCtD
Prazosin—Dizziness—Vandetanib—thyroid cancer	0.00102	0.00898	CcSEcCtD
Prazosin—Vomiting—Vandetanib—thyroid cancer	0.000985	0.00863	CcSEcCtD
Prazosin—Rash—Vandetanib—thyroid cancer	0.000977	0.00856	CcSEcCtD
Prazosin—Dermatitis—Vandetanib—thyroid cancer	0.000976	0.00855	CcSEcCtD
Prazosin—Headache—Vandetanib—thyroid cancer	0.000971	0.0085	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000952	0.00834	CcSEcCtD
Prazosin—Dyspnoea—Sorafenib—thyroid cancer	0.000932	0.00816	CcSEcCtD
Prazosin—Nausea—Vandetanib—thyroid cancer	0.00092	0.00806	CcSEcCtD
Prazosin—ADRA1B—head—thyroid cancer	0.000902	0.041	CbGeAlD
Prazosin—Fatigue—Sorafenib—thyroid cancer	0.000901	0.00789	CcSEcCtD
Prazosin—Pain—Sorafenib—thyroid cancer	0.000894	0.00783	CcSEcCtD
Prazosin—Constipation—Sorafenib—thyroid cancer	0.000894	0.00783	CcSEcCtD
Prazosin—ADRA1D—head—thyroid cancer	0.000882	0.0401	CbGeAlD
Prazosin—Eye pain—Epirubicin—thyroid cancer	0.000871	0.00763	CcSEcCtD
Prazosin—Urticaria—Sorafenib—thyroid cancer	0.00083	0.00727	CcSEcCtD
Prazosin—Body temperature increased—Sorafenib—thyroid cancer	0.000826	0.00724	CcSEcCtD
Prazosin—Eye pain—Doxorubicin—thyroid cancer	0.000806	0.00706	CcSEcCtD
Prazosin—ABCG2—saliva-secreting gland—thyroid cancer	0.000804	0.0365	CbGeAlD
Prazosin—Hypersensitivity—Sorafenib—thyroid cancer	0.00077	0.00675	CcSEcCtD
Prazosin—Asthenia—Sorafenib—thyroid cancer	0.00075	0.00657	CcSEcCtD
Prazosin—Pruritus—Sorafenib—thyroid cancer	0.00074	0.00648	CcSEcCtD
Prazosin—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000718	0.00629	CcSEcCtD
Prazosin—SLC22A3—thyroid gland—thyroid cancer	0.000717	0.0326	CbGeAlD
Prazosin—Diarrhoea—Sorafenib—thyroid cancer	0.000715	0.00626	CcSEcCtD
Prazosin—Dizziness—Sorafenib—thyroid cancer	0.000691	0.00605	CcSEcCtD
Prazosin—Pancreatitis—Epirubicin—thyroid cancer	0.000666	0.00583	CcSEcCtD
Prazosin—SLC22A1—head—thyroid cancer	0.000665	0.0302	CbGeAlD
Prazosin—Vomiting—Sorafenib—thyroid cancer	0.000665	0.00582	CcSEcCtD
Prazosin—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000664	0.00582	CcSEcCtD
Prazosin—Angina pectoris—Epirubicin—thyroid cancer	0.000662	0.0058	CcSEcCtD
Prazosin—HTR1D—head—thyroid cancer	0.000659	0.03	CbGeAlD
Prazosin—Rash—Sorafenib—thyroid cancer	0.000659	0.00577	CcSEcCtD
Prazosin—Dermatitis—Sorafenib—thyroid cancer	0.000658	0.00577	CcSEcCtD
Prazosin—Headache—Sorafenib—thyroid cancer	0.000655	0.00574	CcSEcCtD
Prazosin—SLC22A3—head—thyroid cancer	0.000636	0.0289	CbGeAlD
Prazosin—Pollakiuria—Epirubicin—thyroid cancer	0.000628	0.0055	CcSEcCtD
Prazosin—Nausea—Sorafenib—thyroid cancer	0.000621	0.00544	CcSEcCtD
Prazosin—Pancreatitis—Doxorubicin—thyroid cancer	0.000616	0.0054	CcSEcCtD
Prazosin—Angina pectoris—Doxorubicin—thyroid cancer	0.000612	0.00536	CcSEcCtD
Prazosin—Drowsiness—Epirubicin—thyroid cancer	0.000606	0.00531	CcSEcCtD
Prazosin—CYP1A1—trachea—thyroid cancer	0.000589	0.0267	CbGeAlD
Prazosin—Pollakiuria—Doxorubicin—thyroid cancer	0.000581	0.00509	CcSEcCtD
Prazosin—Epistaxis—Epirubicin—thyroid cancer	0.000571	0.005	CcSEcCtD
Prazosin—Drowsiness—Doxorubicin—thyroid cancer	0.00056	0.00491	CcSEcCtD
Prazosin—Bradycardia—Epirubicin—thyroid cancer	0.000554	0.00485	CcSEcCtD
Prazosin—HTR1A—head—thyroid cancer	0.00055	0.025	CbGeAlD
Prazosin—ADRA2A—trachea—thyroid cancer	0.000549	0.0249	CbGeAlD
Prazosin—Epistaxis—Doxorubicin—thyroid cancer	0.000529	0.00463	CcSEcCtD
Prazosin—Bradycardia—Doxorubicin—thyroid cancer	0.000512	0.00449	CcSEcCtD
Prazosin—ORM1—lymph node—thyroid cancer	0.000509	0.0231	CbGeAlD
Prazosin—Tinnitus—Epirubicin—thyroid cancer	0.000507	0.00444	CcSEcCtD
Prazosin—ADRA1A—head—thyroid cancer	0.000507	0.023	CbGeAlD
Prazosin—Flushing—Epirubicin—thyroid cancer	0.000505	0.00442	CcSEcCtD
Prazosin—ABCG2—thyroid gland—thyroid cancer	0.000491	0.0223	CbGeAlD
Prazosin—KCNH2—head—thyroid cancer	0.000489	0.0222	CbGeAlD
Prazosin—Alopecia—Epirubicin—thyroid cancer	0.000481	0.00421	CcSEcCtD
Prazosin—Tinnitus—Doxorubicin—thyroid cancer	0.000469	0.00411	CcSEcCtD
Prazosin—Flushing—Doxorubicin—thyroid cancer	0.000467	0.00409	CcSEcCtD
Prazosin—CYP1A1—thyroid gland—thyroid cancer	0.000466	0.0212	CbGeAlD
Prazosin—Tension—Epirubicin—thyroid cancer	0.000465	0.00407	CcSEcCtD
Prazosin—Nervousness—Epirubicin—thyroid cancer	0.00046	0.00403	CcSEcCtD
Prazosin—Vision blurred—Epirubicin—thyroid cancer	0.000446	0.00391	CcSEcCtD
Prazosin—SLC22A3—lymph node—thyroid cancer	0.000445	0.0202	CbGeAlD
Prazosin—Alopecia—Doxorubicin—thyroid cancer	0.000445	0.00389	CcSEcCtD
Prazosin—Ill-defined disorder—Epirubicin—thyroid cancer	0.000439	0.00385	CcSEcCtD
Prazosin—ADRA2A—thyroid gland—thyroid cancer	0.000434	0.0197	CbGeAlD
Prazosin—Tension—Doxorubicin—thyroid cancer	0.00043	0.00376	CcSEcCtD
Prazosin—Malaise—Epirubicin—thyroid cancer	0.000427	0.00374	CcSEcCtD
Prazosin—Nervousness—Doxorubicin—thyroid cancer	0.000425	0.00373	CcSEcCtD
Prazosin—Vertigo—Epirubicin—thyroid cancer	0.000425	0.00372	CcSEcCtD
Prazosin—Syncope—Epirubicin—thyroid cancer	0.000424	0.00372	CcSEcCtD
Prazosin—Palpitations—Epirubicin—thyroid cancer	0.000418	0.00366	CcSEcCtD
Prazosin—Loss of consciousness—Epirubicin—thyroid cancer	0.000416	0.00364	CcSEcCtD
Prazosin—CYP1A1—head—thyroid cancer	0.000413	0.0188	CbGeAlD
Prazosin—Vision blurred—Doxorubicin—thyroid cancer	0.000413	0.00362	CcSEcCtD
Prazosin—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000406	0.00356	CcSEcCtD
Prazosin—Arthralgia—Epirubicin—thyroid cancer	0.000403	0.00353	CcSEcCtD
Prazosin—Discomfort—Epirubicin—thyroid cancer	0.000398	0.00349	CcSEcCtD
Prazosin—Malaise—Doxorubicin—thyroid cancer	0.000395	0.00346	CcSEcCtD
Prazosin—Dry mouth—Epirubicin—thyroid cancer	0.000394	0.00345	CcSEcCtD
Prazosin—Vertigo—Doxorubicin—thyroid cancer	0.000394	0.00345	CcSEcCtD
Prazosin—Syncope—Doxorubicin—thyroid cancer	0.000393	0.00344	CcSEcCtD
Prazosin—Palpitations—Doxorubicin—thyroid cancer	0.000387	0.00339	CcSEcCtD
Prazosin—Oedema—Epirubicin—thyroid cancer	0.000386	0.00338	CcSEcCtD
Prazosin—ADRA2A—head—thyroid cancer	0.000385	0.0175	CbGeAlD
Prazosin—Loss of consciousness—Doxorubicin—thyroid cancer	0.000385	0.00337	CcSEcCtD
Prazosin—Shock—Epirubicin—thyroid cancer	0.00038	0.00333	CcSEcCtD
Prazosin—Tachycardia—Epirubicin—thyroid cancer	0.000377	0.0033	CcSEcCtD
Prazosin—Hyperhidrosis—Epirubicin—thyroid cancer	0.000373	0.00327	CcSEcCtD
Prazosin—Arthralgia—Doxorubicin—thyroid cancer	0.000373	0.00327	CcSEcCtD
Prazosin—Discomfort—Doxorubicin—thyroid cancer	0.000368	0.00323	CcSEcCtD
Prazosin—Dry mouth—Doxorubicin—thyroid cancer	0.000365	0.00319	CcSEcCtD
Prazosin—Oedema—Doxorubicin—thyroid cancer	0.000357	0.00313	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000352	0.00308	CcSEcCtD
Prazosin—Shock—Doxorubicin—thyroid cancer	0.000352	0.00308	CcSEcCtD
Prazosin—Insomnia—Epirubicin—thyroid cancer	0.000349	0.00306	CcSEcCtD
Prazosin—Tachycardia—Doxorubicin—thyroid cancer	0.000349	0.00306	CcSEcCtD
Prazosin—Paraesthesia—Epirubicin—thyroid cancer	0.000347	0.00304	CcSEcCtD
Prazosin—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000346	0.00303	CcSEcCtD
Prazosin—Dyspnoea—Epirubicin—thyroid cancer	0.000344	0.00302	CcSEcCtD
Prazosin—Somnolence—Epirubicin—thyroid cancer	0.000343	0.00301	CcSEcCtD
Prazosin—KCNH2—lymph node—thyroid cancer	0.000343	0.0156	CbGeAlD
Prazosin—Fatigue—Epirubicin—thyroid cancer	0.000333	0.00292	CcSEcCtD
Prazosin—Pain—Epirubicin—thyroid cancer	0.00033	0.00289	CcSEcCtD
Prazosin—Constipation—Epirubicin—thyroid cancer	0.00033	0.00289	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000326	0.00285	CcSEcCtD
Prazosin—Insomnia—Doxorubicin—thyroid cancer	0.000323	0.00283	CcSEcCtD
Prazosin—Paraesthesia—Doxorubicin—thyroid cancer	0.000321	0.00281	CcSEcCtD
Prazosin—Dyspnoea—Doxorubicin—thyroid cancer	0.000319	0.00279	CcSEcCtD
Prazosin—Feeling abnormal—Epirubicin—thyroid cancer	0.000318	0.00279	CcSEcCtD
Prazosin—Somnolence—Doxorubicin—thyroid cancer	0.000318	0.00278	CcSEcCtD
Prazosin—Fatigue—Doxorubicin—thyroid cancer	0.000308	0.0027	CcSEcCtD
Prazosin—Urticaria—Epirubicin—thyroid cancer	0.000307	0.00269	CcSEcCtD
Prazosin—ABCB1—trachea—thyroid cancer	0.000306	0.0139	CbGeAlD
Prazosin—Pain—Doxorubicin—thyroid cancer	0.000306	0.00268	CcSEcCtD
Prazosin—Constipation—Doxorubicin—thyroid cancer	0.000306	0.00268	CcSEcCtD
Prazosin—Body temperature increased—Epirubicin—thyroid cancer	0.000305	0.00267	CcSEcCtD
Prazosin—ABCG2—lymph node—thyroid cancer	0.000305	0.0138	CbGeAlD
Prazosin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000295	0.00258	CcSEcCtD
Prazosin—CYP1A1—lymph node—thyroid cancer	0.000289	0.0131	CbGeAlD
Prazosin—Hypersensitivity—Epirubicin—thyroid cancer	0.000285	0.00249	CcSEcCtD
Prazosin—Urticaria—Doxorubicin—thyroid cancer	0.000284	0.00249	CcSEcCtD
Prazosin—Body temperature increased—Doxorubicin—thyroid cancer	0.000283	0.00248	CcSEcCtD
Prazosin—Asthenia—Epirubicin—thyroid cancer	0.000277	0.00243	CcSEcCtD
Prazosin—Pruritus—Epirubicin—thyroid cancer	0.000273	0.00239	CcSEcCtD
Prazosin—ADRA2A—lymph node—thyroid cancer	0.00027	0.0123	CbGeAlD
Prazosin—Diarrhoea—Epirubicin—thyroid cancer	0.000264	0.00232	CcSEcCtD
Prazosin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000263	0.00231	CcSEcCtD
Prazosin—Asthenia—Doxorubicin—thyroid cancer	0.000256	0.00225	CcSEcCtD
Prazosin—Dizziness—Epirubicin—thyroid cancer	0.000255	0.00224	CcSEcCtD
Prazosin—Pruritus—Doxorubicin—thyroid cancer	0.000253	0.00222	CcSEcCtD
Prazosin—Vomiting—Epirubicin—thyroid cancer	0.000246	0.00215	CcSEcCtD
Prazosin—Diarrhoea—Doxorubicin—thyroid cancer	0.000245	0.00214	CcSEcCtD
Prazosin—Rash—Epirubicin—thyroid cancer	0.000244	0.00213	CcSEcCtD
Prazosin—Dermatitis—Epirubicin—thyroid cancer	0.000243	0.00213	CcSEcCtD
Prazosin—Headache—Epirubicin—thyroid cancer	0.000242	0.00212	CcSEcCtD
Prazosin—ABCB1—thyroid gland—thyroid cancer	0.000242	0.011	CbGeAlD
Prazosin—Dizziness—Doxorubicin—thyroid cancer	0.000236	0.00207	CcSEcCtD
Prazosin—Nausea—Epirubicin—thyroid cancer	0.000229	0.00201	CcSEcCtD
Prazosin—Vomiting—Doxorubicin—thyroid cancer	0.000227	0.00199	CcSEcCtD
Prazosin—Rash—Doxorubicin—thyroid cancer	0.000225	0.00197	CcSEcCtD
Prazosin—Dermatitis—Doxorubicin—thyroid cancer	0.000225	0.00197	CcSEcCtD
Prazosin—Headache—Doxorubicin—thyroid cancer	0.000224	0.00196	CcSEcCtD
Prazosin—ABCB1—head—thyroid cancer	0.000215	0.00975	CbGeAlD
Prazosin—Nausea—Doxorubicin—thyroid cancer	0.000212	0.00186	CcSEcCtD
Prazosin—ABCB1—lymph node—thyroid cancer	0.00015	0.00683	CbGeAlD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.69e-05	0.000776	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TSHR—thyroid cancer	3.69e-05	0.000774	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—CDK1—thyroid cancer	3.69e-05	0.000774	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—PTCH1—thyroid cancer	3.66e-05	0.000769	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—SST—thyroid cancer	3.66e-05	0.000769	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—HPGD—thyroid cancer	3.64e-05	0.000764	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—PTCH1—thyroid cancer	3.63e-05	0.000763	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PRKAR1A—thyroid cancer	3.63e-05	0.000762	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—SST—thyroid cancer	3.58e-05	0.000752	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—TPR—thyroid cancer	3.56e-05	0.000748	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—CALCA—thyroid cancer	3.52e-05	0.00074	CbGpPWpGaD
Prazosin—SLC22A2—Transmission across Chemical Synapses—HRAS—thyroid cancer	3.52e-05	0.00074	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—CDK1—thyroid cancer	3.51e-05	0.000737	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	3.51e-05	0.000737	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PRKAR1A—thyroid cancer	3.5e-05	0.000736	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MEN1—thyroid cancer	3.47e-05	0.000728	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TCF7L1—thyroid cancer	3.45e-05	0.000725	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CALCA—thyroid cancer	3.44e-05	0.000723	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—SST—thyroid cancer	3.35e-05	0.000704	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.34e-05	0.000701	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TSHR—thyroid cancer	3.33e-05	0.000699	CbGpPWpGaD
Prazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	3.33e-05	0.000699	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—SST—thyroid cancer	3.32e-05	0.000698	CbGpPWpGaD
Prazosin—SLC22A1—Transmission across Chemical Synapses—HRAS—thyroid cancer	3.28e-05	0.00069	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PRKAR1A—thyroid cancer	3.27e-05	0.000688	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CALCA—thyroid cancer	3.22e-05	0.000677	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TSHR—thyroid cancer	3.21e-05	0.000675	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CALCA—thyroid cancer	3.2e-05	0.000672	CbGpPWpGaD
Prazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	3.18e-05	0.000669	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	3.17e-05	0.000666	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PRKAR1A—thyroid cancer	3.16e-05	0.000664	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PTCH1—thyroid cancer	3.13e-05	0.000658	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MEN1—thyroid cancer	3.13e-05	0.000657	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CDK1—thyroid cancer	3.12e-05	0.000655	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TSHR—thyroid cancer	3.06e-05	0.000643	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	3.06e-05	0.000643	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MEN1—thyroid cancer	3.02e-05	0.000635	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—TPR—thyroid cancer	3.02e-05	0.000634	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PRKAR1A—thyroid cancer	3.01e-05	0.000632	CbGpPWpGaD
Prazosin—ADRA2B—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	2.99e-05	0.000628	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PRKAR1A—thyroid cancer	2.97e-05	0.000624	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CDK1—thyroid cancer	2.92e-05	0.000613	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CDK1—thyroid cancer	2.9e-05	0.000608	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—SLC5A5—thyroid cancer	2.89e-05	0.000607	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MEN1—thyroid cancer	2.88e-05	0.000604	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—SST—thyroid cancer	2.87e-05	0.000602	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—SLC5A5—thyroid cancer	2.86e-05	0.000601	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PTCH1—thyroid cancer	2.83e-05	0.000594	CbGpPWpGaD
Prazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	2.83e-05	0.000594	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.8e-05	0.000589	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CALCA—thyroid cancer	2.76e-05	0.00058	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PTCH1—thyroid cancer	2.73e-05	0.000574	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TSHR—thyroid cancer	2.72e-05	0.000571	CbGpPWpGaD
Prazosin—SLC22A2—Neuronal System—HRAS—thyroid cancer	2.7e-05	0.000567	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PRKAR1A—thyroid cancer	2.67e-05	0.000562	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—SLC5A5—thyroid cancer	2.67e-05	0.00056	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—TPR—thyroid cancer	2.61e-05	0.000549	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PTCH1—thyroid cancer	2.6e-05	0.000546	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—SST—thyroid cancer	2.59e-05	0.000544	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	2.57e-05	0.00054	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MEN1—thyroid cancer	2.56e-05	0.000537	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TSHR—thyroid cancer	2.53e-05	0.00053	CbGpPWpGaD
Prazosin—SLC22A1—Neuronal System—HRAS—thyroid cancer	2.52e-05	0.000528	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—SST—thyroid cancer	2.5e-05	0.000525	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CDK1—thyroid cancer	2.5e-05	0.000525	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CALCA—thyroid cancer	2.49e-05	0.000523	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PRKAR1A—thyroid cancer	2.48e-05	0.000522	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—RXRA—thyroid cancer	2.43e-05	0.00051	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—PPARG—thyroid cancer	2.42e-05	0.000508	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CALCA—thyroid cancer	2.4e-05	0.000505	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—RXRA—thyroid cancer	2.4e-05	0.000505	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—NRAS—thyroid cancer	2.39e-05	0.000501	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—SST—thyroid cancer	2.38e-05	0.0005	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MEN1—thyroid cancer	2.37e-05	0.000499	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.35e-05	0.000493	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—NRG1—thyroid cancer	2.34e-05	0.000492	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.33e-05	0.00049	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PTCH1—thyroid cancer	2.31e-05	0.000485	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CALCA—thyroid cancer	2.29e-05	0.000481	CbGpPWpGaD
Prazosin—ADRA2A—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	2.27e-05	0.000477	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—SLC5A5—thyroid cancer	2.26e-05	0.000475	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CDK1—thyroid cancer	2.26e-05	0.000474	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—RXRA—thyroid cancer	2.24e-05	0.000471	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CDK1—thyroid cancer	2.18e-05	0.000457	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PTCH1—thyroid cancer	2.15e-05	0.000451	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SST—thyroid cancer	2.11e-05	0.000444	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TERT—thyroid cancer	2.1e-05	0.000442	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—TPR—thyroid cancer	2.09e-05	0.000439	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2.09e-05	0.000439	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CDK1—thyroid cancer	2.07e-05	0.000435	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PRKAR1A—thyroid cancer	2.05e-05	0.000432	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—KRAS—thyroid cancer	2.05e-05	0.000431	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CALCA—thyroid cancer	2.03e-05	0.000427	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—HIF1A—thyroid cancer	2.01e-05	0.000423	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—NRG1—thyroid cancer	2e-05	0.000421	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SST—thyroid cancer	1.96e-05	0.000413	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—SLC5A5—thyroid cancer	1.96e-05	0.000411	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—PTGS2—thyroid cancer	1.9e-05	0.0004	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—RXRA—thyroid cancer	1.9e-05	0.000399	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CALCA—thyroid cancer	1.89e-05	0.000397	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CDK1—thyroid cancer	1.84e-05	0.000387	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.83e-05	0.000385	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—TP53—thyroid cancer	1.83e-05	0.000383	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—NRAS—thyroid cancer	1.81e-05	0.00038	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—NRG1—thyroid cancer	1.81e-05	0.00038	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TERT—thyroid cancer	1.8e-05	0.000378	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—NRAS—thyroid cancer	1.77e-05	0.000372	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.76e-05	0.00037	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—NRG1—thyroid cancer	1.75e-05	0.000367	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—HRAS—thyroid cancer	1.75e-05	0.000367	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—HIF1A—thyroid cancer	1.72e-05	0.000362	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CDK1—thyroid cancer	1.71e-05	0.000359	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—BRAF—thyroid cancer	1.67e-05	0.00035	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—NRG1—thyroid cancer	1.66e-05	0.00035	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—PTEN—thyroid cancer	1.66e-05	0.000349	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—RXRA—thyroid cancer	1.64e-05	0.000345	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TERT—thyroid cancer	1.63e-05	0.000341	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.6e-05	0.000336	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TERT—thyroid cancer	1.57e-05	0.00033	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.56e-05	0.000328	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—KRAS—thyroid cancer	1.56e-05	0.000327	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—HIF1A—thyroid cancer	1.55e-05	0.000327	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—AKT1—thyroid cancer	1.54e-05	0.000324	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PPARG—thyroid cancer	1.53e-05	0.000322	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—KRAS—thyroid cancer	1.53e-05	0.00032	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PPARG—thyroid cancer	1.52e-05	0.000319	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—NRAS—thyroid cancer	1.52e-05	0.000319	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—HIF1A—thyroid cancer	1.5e-05	0.000315	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TERT—thyroid cancer	1.49e-05	0.000314	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—NRG1—thyroid cancer	1.48e-05	0.000311	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—HIF1A—thyroid cancer	1.43e-05	0.0003	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—BRAF—thyroid cancer	1.43e-05	0.000299	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PPARG—thyroid cancer	1.41e-05	0.000297	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—TP53—thyroid cancer	1.38e-05	0.000291	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—NRG1—thyroid cancer	1.37e-05	0.000289	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—NRAS—thyroid cancer	1.37e-05	0.000288	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TERT—thyroid cancer	1.33e-05	0.000279	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—HRAS—thyroid cancer	1.32e-05	0.000278	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—NRAS—thyroid cancer	1.32e-05	0.000278	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—RXRA—thyroid cancer	1.31e-05	0.000276	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—KRAS—thyroid cancer	1.31e-05	0.000274	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—HRAS—thyroid cancer	1.3e-05	0.000272	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—BRAF—thyroid cancer	1.29e-05	0.00027	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HIF1A—thyroid cancer	1.27e-05	0.000267	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—AKT1—thyroid cancer	1.26e-05	0.000265	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—NRAS—thyroid cancer	1.26e-05	0.000264	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—BRAF—thyroid cancer	1.24e-05	0.000261	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TERT—thyroid cancer	1.23e-05	0.000259	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CCND1—thyroid cancer	1.22e-05	0.000255	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PTGS2—thyroid cancer	1.21e-05	0.000253	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PPARG—thyroid cancer	1.2e-05	0.000252	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PTGS2—thyroid cancer	1.19e-05	0.000251	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—BRAF—thyroid cancer	1.18e-05	0.000249	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	1.18e-05	0.000248	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—KRAS—thyroid cancer	1.18e-05	0.000248	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—PTEN—thyroid cancer	1.17e-05	0.000246	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—AKT1—thyroid cancer	1.17e-05	0.000246	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—AKT1—thyroid cancer	1.14e-05	0.00024	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	1.14e-05	0.000239	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—NRAS—thyroid cancer	1.12e-05	0.000235	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PTGS2—thyroid cancer	1.11e-05	0.000234	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—HRAS—thyroid cancer	1.11e-05	0.000233	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—KRAS—thyroid cancer	1.08e-05	0.000228	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—AKT1—thyroid cancer	1.08e-05	0.000227	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PTEN—thyroid cancer	1.05e-05	0.000221	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—BRAF—thyroid cancer	1.05e-05	0.000221	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—NRAS—thyroid cancer	1.05e-05	0.00022	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PTEN—thyroid cancer	1.04e-05	0.000219	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CCND1—thyroid cancer	1.04e-05	0.000219	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	1.04e-05	0.000218	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PPARG—thyroid cancer	1.04e-05	0.000218	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PTEN—thyroid cancer	1e-05	0.000211	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—HRAS—thyroid cancer	1e-05	0.00021	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—AKT1—thyroid cancer	9.8e-06	0.000206	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	9.77e-06	0.000205	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—AKT1—thyroid cancer	9.74e-06	0.000205	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PTEN—thyroid cancer	9.71e-06	0.000204	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	9.67e-06	0.000203	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—KRAS—thyroid cancer	9.62e-06	0.000202	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—AKT1—thyroid cancer	9.57e-06	0.000201	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PTGS2—thyroid cancer	9.43e-06	0.000198	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	9.4e-06	0.000198	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCND1—thyroid cancer	9.39e-06	0.000197	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—HRAS—thyroid cancer	9.21e-06	0.000193	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCND1—thyroid cancer	9.07e-06	0.00019	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PTEN—thyroid cancer	9.07e-06	0.00019	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—KRAS—thyroid cancer	9.01e-06	0.000189	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—NRAS—thyroid cancer	8.96e-06	0.000188	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—AKT1—thyroid cancer	8.95e-06	0.000188	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	8.94e-06	0.000188	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—AKT1—thyroid cancer	8.85e-06	0.000186	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PTEN—thyroid cancer	8.75e-06	0.000184	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCND1—thyroid cancer	8.64e-06	0.000181	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	8.54e-06	0.000179	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PTEN—thyroid cancer	8.34e-06	0.000175	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PPARG—thyroid cancer	8.29e-06	0.000174	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PTEN—thyroid cancer	8.23e-06	0.000173	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	8.18e-06	0.000172	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PTGS2—thyroid cancer	8.17e-06	0.000172	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—AKT1—thyroid cancer	8.13e-06	0.000171	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—NRAS—thyroid cancer	8.09e-06	0.00017	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TP53—thyroid cancer	8.01e-06	0.000168	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	7.95e-06	0.000167	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—NRAS—thyroid cancer	7.81e-06	0.000164	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—KRAS—thyroid cancer	7.71e-06	0.000162	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	7.67e-06	0.000161	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—HRAS—thyroid cancer	7.66e-06	0.000161	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	7.6e-06	0.00016	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—NRAS—thyroid cancer	7.44e-06	0.000156	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	7.4e-06	0.000156	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	7.39e-06	0.000155	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	7.22e-06	0.000152	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	7.13e-06	0.00015	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PTEN—thyroid cancer	7.12e-06	0.00015	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—KRAS—thyroid cancer	6.96e-06	0.000146	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	6.88e-06	0.000145	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TP53—thyroid cancer	6.85e-06	0.000144	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—AKT1—thyroid cancer	6.76e-06	0.000142	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—KRAS—thyroid cancer	6.72e-06	0.000141	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	6.71e-06	0.000141	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	6.61e-06	0.000139	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—HRAS—thyroid cancer	6.55e-06	0.000138	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PTGS2—thyroid cancer	6.52e-06	0.000137	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—KRAS—thyroid cancer	6.4e-06	0.000134	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TP53—thyroid cancer	6.19e-06	0.00013	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	6.14e-06	0.000129	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—AKT1—thyroid cancer	6.06e-06	0.000127	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—AKT1—thyroid cancer	6e-06	0.000126	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TP53—thyroid cancer	5.97e-06	0.000125	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—HRAS—thyroid cancer	5.92e-06	0.000124	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—AKT1—thyroid cancer	5.79e-06	0.000122	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—HRAS—thyroid cancer	5.71e-06	0.00012	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PTEN—thyroid cancer	5.69e-06	0.00012	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TP53—thyroid cancer	5.69e-06	0.000119	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	5.69e-06	0.000119	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—AKT1—thyroid cancer	5.59e-06	0.000118	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—HRAS—thyroid cancer	5.44e-06	0.000114	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	5.28e-06	0.000111	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—AKT1—thyroid cancer	5.23e-06	0.00011	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TP53—thyroid cancer	5.05e-06	0.000106	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—AKT1—thyroid cancer	5.04e-06	0.000106	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	4.83e-06	0.000102	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—AKT1—thyroid cancer	4.8e-06	0.000101	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—AKT1—thyroid cancer	4.74e-06	9.96e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TP53—thyroid cancer	4.69e-06	9.86e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	4.49e-06	9.43e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	4.27e-06	8.96e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—AKT1—thyroid cancer	4.1e-06	8.62e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	3.96e-06	8.33e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—AKT1—thyroid cancer	3.28e-06	6.89e-05	CbGpPWpGaD
